Oral Darolutamide presentation at ASCO on 31 May 2019

Impact of Darolutamide on Pain and Quality of Life in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer (nmCRPC) at ASCO taking place in Chicago.

Read more

Capital Markets Day 2019

Orion's Capital Markets Day was held on Wednesday 22 May 2019.

Read more

AGM 2019

The 2019 Annual General Meeting was held on 26 March 2019 in Helsinki. Read more here.

Read more

Share information

Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.

Read more

Major shareholders by votes

Monthly updated list of Orion's major shareholders by votes.

Read more

Orion's R&D Pipeline

Read more

Orion Executive Management Board

The members of the Board of Directors

Orion included in FTSE4Good Index

Orion Corporation has been included in the globally recognised FTSE4Good Index.

Read more

Our approach to corporate responsibility